1. Home
  2. News
  3. Racura Oncology Ltd
  4. Race reveals new strategy for cancer drug Bisantrene
More Racura Oncology Ltd news
Racura Oncology LtdASX: RAC

Race reveals new strategy for cancer drug Bisantrene

Nov 14, 2019 at 1:51 AM EST · Issued by Racura Oncology Ltd

Filed with ASX · Nov 14, 2019 at 1:51 AM EST · 27 pages · English

On 6ix: 6ix.com/news/race-reveals-new-strategy-for-cancer-drug-bisantrene

Racura Oncology Ltd on 6ix

Earlier from Racura Oncology

  • Appendix 4C - quarterlyOct 17, 2019
  • Prominent biotech investor leads investment in RaceAug 19, 2019
  • First patient treated in Bisantrene trial in IsraelJul 24, 2019
  • Bisantrene AML trial to start in IsraelMay 13, 2019
  • Bisantrene IND UpdateApr 24, 2019

Later from Racura Oncology

  • Race Receives $159k R&D Tax Incentive RefundDec 16, 2019
  • December 2019 Quarterly ReportJan 29, 2020
  • Race Secures A$1.8m strategic placementMar 5, 2020
  • Race starts preclinical breast cancer study for BisantreneMay 13, 2020
  • Managing Director ResignationMay 20, 2020
All Racura Oncology news releases↗

Follow Racura Oncology into a list and get an email when it puts out news.

Follow Racura Oncology
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer